Introduction
Methods
Study periods
Aims of the study
Targets and nutrition protocols
ICU management
Clinical and biological data
Before group (n = 147) | After group (n = 128) | p value | |
---|---|---|---|
Sex (female) | 63 (43) | 48 (37) | 0.37 |
Age (years) | 58 [46–66] | 60 [52–68] | 0.14 |
Height (cm) | 170 [164–175] | 170 [165–175] | 0.33 |
Weight at ICU admission (kg) | 75 [63–83] | 73 [65–87] | 0.32 |
Weight at ICU discharge (kg) | 70.00 [59–80] | 70.00 [60–82] | 0.84 |
Weight loss at ICU discharge (kg) | 1.00 [0.00–3.00] | 0.00 [–0.50–2.00] | 0.53 |
BMI | 24 (21–28) | 24 (22–27) | 0.84 |
Nutritional status | |||
No or Mild malnutrition | 119 (81) | 95 (74) | 0.18 |
Severe malnutrition | 27 (19) | 33 (26) | 0.14 |
Oral alimentation at ICU discharge | 92 (63) | 75 (59) | 0.50 |
SAPSII score | 46 [36–59] | 48.50 [40–58] | 0.38 |
Severe patients (SAPSII > 56) | 41 (28) | 40 (31) | 0.54 |
Comorbidities | |||
Cardiovascular | 46 (31) | 47 (37) | 0.34 |
Respiratory | 37 (25) | 42 (33) | 0.73 |
Hepatic | 8 (5) | 5 (4) | 0.55 |
Renal | 11 (7) | 5 (4) | 0.21 |
Neurologic | 11 (7) | 8 (6) | 0.69 |
Diabetes | 16 (11) | 12 (9) | 0.70 |
Hematology disease | |||
AML | 56 (38) | 35 (27) | 0.06 |
ALL | 18 (12) | 4 (3) | 0.006 |
Lymphoma | 40 (27) | 50 (39) | 0.04 |
Myeloma | 17 (12) | 14 (11) | 0.87 |
Autologous SCT | 27 (18) | 30 (23) | 0.30 |
Allogeneic SCT | 32 (22) | 38 (30) | 0.13 |
Neutropenia | 43 (29) | 57 (45) | 0.009 |
CML, CLL | 16 (11) | 25 (20) | 0.04 |
Complete remission | 43 (34) | 31 (24) | 0.1 |
Main cause for ICU admission | |||
ARF | 50 (34) | 56 (44) | 0.1 |
Shock | 48 (33) | 35 (27) | 0.36 |
AKI | 18 (12) | 6 (5) | 0.03 |
Neurologic failure | 11 (7) | 15 (12) | 0.23 |
Others | 20 (14) | 16 (12) | 0.79 |
Organ support | |||
IMV | 72 (49) | 59 (46) | 0.72 |
Vasopressors | 83 (56) | 72 (56) | 1 |
RRT | 32 (22) | 35 (27) | 0.32 |
ICU length of stay (days) | 11 (13) | 14 (13) | 0.06 |
Hospital mortality | 72 (49) | 54 (42) | 0.28 |
Hospital length of stay (days) | 38 (41) | 37 (28) | 0.94 |
Statistical analysis
Results
Clinical parameters (Table 1)
Nutritional parameters
‘Before group’ | ‘After group’ | Intensity rate ratio |
p
| |||
---|---|---|---|---|---|---|
Number of days in ICU days within target | Intensity rate | Number of days in days within target | Intensity rate | |||
All patients | n = 147 | n = 128 | ||||
Calories |
2.08 (4.29)
| 18.4% [14.4–23.5%] |
4.13 (6.13)
| 28.8% [24.6–33.7%] |
1.57 [1.17–2.10]
|
0.0025
|
Proteins |
0.83 (3.09)
| 7.3% [4.3–12.5%] |
4.09 (5.55)
| 28.3% [24.4–32.8%] |
3.86 [2.21–6.73]
| < 0.0001 |
Subgroup analysis | ||||||
Neutropenic | n = 43 | n = 57 | ||||
Calories | 2.28 (4.04) | 23.4% [15.2–36.0%] | 5.33 (6.53) | 33.7% [27.4–41.5%] | 1.44 [0.89–2.33] | 0.13 |
Proteins | 0.86 (3.14) | 8.8% [3.1–24.8%] | 4.61 (5.29) | 29.2% [24.4–35.0%] | 3.31 [1.16–9.43] | 0.025 |
Severe patients | n = 41 | n = 40 | ||||
Calories | 2.00 (3.26) | 20.9% [13.6–32.0%] | 3.75 (4.01) | 26.1% [20.2–33.8%] | 1.25 [0.76–2.07] | 0.38 |
Proteins |
0.49 (1.50)
| 5.1% [2.0–12.6%] |
3.41 (4.75)
| 23.3% [18.3–29.8%] |
4.59 [1.79–11.76]
|
0.0015
|
Allogeneic HSCT | n = 32 | n = 38 | ||||
Calories | 2.56 (3.72) | 23.6% [15.5–35.8%] | 4.42 (4.62) | 29.8% [23.8–37.4%] | 1.27 [0.79–2.04] | 0.33 |
Proteins | 1.47 (4.65) | 13.5% [5.2–34.9%] | 4.34 (5.00) | 29.3% [22.4–38.4%] | 2.17 [0.81–5.82] | 0.12 |
‘Before group’ (n = 147) | ‘After group’ (n = 128) | Intensity rate ratio [CI 95%] |
p
| |||
---|---|---|---|---|---|---|
Intensity rate | Intensity rate | |||||
Support | ||||||
Days with IMV | 3.99 (7.45) | 35.2% [28.6–43.3%] | 4.83 (8.89) | 33.7% [27.0–42.1%] | 0.96 [0.71–1.30] | 0.79 |
Days with vasopressors | 2.76 (4.16) | 24.3% [18.9–31.3%] | 2.56 (3.35) | 17.9% [14.5–22.1%] | 0.74 [0.53–1.02] | 0.07 |
Days with dialysis | 1.06 (2.67) | 9.4% [6.2–14.2%] | 2.06 (4.72) | 14.4% [10.3–20.2%] | 1.54 [0.90–2.63] | 0.12 |
Days with antibiotics | 8.90 (7.85) | 78.3% [69.4–88.3%] | 12.38 (11.34) | 86.4% [81.9–91.2%] | 1.10 [0.97–1.26] | 0.14 |
Number of antibiotics used during ICU stay | 3.07 (1.86) | 3.52 (2.03) | 0.91 [0.73–1.12] | 0.37 | ||
Infections | ||||||
ICU-acquired infection | 34 (23.13) | 40 (31.25) | 0.13 | |||
VAP | 18 (12.24) | 16 (12.50) | 0.95 | |||
Bacteremia | 12 (8.16) | 18 (14.06) | 0.12 | |||
CVC-related infection | 4 (2.72) | 4 (3.13) | 1 | |||
Urinary tract infection | 5 (3.40) | 8 (6.25) | 0.27 |